is a clinical stage regenerative Medicine Company focused on developing and commercializing tissue repair products, initially for orthobiologics and advanced wound care markets. Our products are based on our rhCollagen (recombinant human collagen) that is produced with our proprietary plant based genetic engineering technology.

Our product candidates answer acute unmet needs in diverse fields of tissue repair and are ushering in a new era in regenerative medicine. Our flagship Vergenix line of rhCollagen products include a bone graft matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound filler to promote rapid optimal healing of acute and chronic wounds.

Our Mission

seeks to reshape the field of tissue repair through innovative, safe and readily-available products.

    Our Product Candidates 

is a Bone Graft Matrix indicated for spinal fusion procedures in posterolateral approach.

read more
is a Soft Tissue Repair Matrix indicated for the treatment of tendinopathy.

read more
is a Wound Filler indicated
for the treatment of acute
and chronic wounds.

read more